Literature DB >> 1281197

T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni.

S R Reynolds1, C B Shoemaker, D A Harn.   

Abstract

SM23 is an integral membrane protein of the blood-vessel dwelling parasitic worm Schistosoma mansoni. This protein has been detected with antibodies in all stages of the parasite found in the human host, notably the lung stage, and therefore is of interest as a vaccine candidate. In addition SM23 has been shown to be a member of a proposed new superfamily of membrane proteins whose structures do not conform to the previously known classifications. To date there are 13 members including ME491 (CD63, Pltgp40), CD9 (p23), TAPA-1, CD37, CD53, MRC OX-44, CO-029, MRP-1, L6, the gene product of TI-1, the target of mAb AD-1, SM23, and SJ23 (the Schistosoma japonicum homologue). Most of these molecules except for those in the two blood vessel-dwelling parasites are found in membranes of hemopoietic and/or malignant cells and all have unknown function. In this study we used recombinantly expressed full-length and partial molecules as well as synthesized peptides to map T cell and B cell epitopes of SM23. The two predicted external hydrophilic domains were found to be highly immunogenic and contained several B cell epitopes. There were at least four T cell epitopes in the large hydrophilic domain. One segment of 23 amino acids contained both a T cell and B cell epitope as well as the putative glycosylation site. This particular segment was recognized by immune sera and cells of every mouse strain tested. The elucidation of these epitopes demonstrates the immunogenic nature of this molecule and raises questions as to the role of SM23 in the host/parasite relationship.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281197

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

Authors:  T Ben-Yedidia; R Tarrab-Hazdai; D Schechtman; R Arnon
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Human immune responses to Schistosoma mansoni vaccine candidate antigens.

Authors:  A Ribeiro de Jesus; I Araújo; O Bacellar; A Magalhães; E Pearce; D Harn; M Strand; E M Carvalho
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  Screening the Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in search for vaccine candidates.

Authors:  Leonardo P Farias; Cibele A Tararam; Patricia A Miyasato; Milton Y Nishiyama; Katia C Oliveira; Toshie Kawano; Sergio Verjovski-Almeida; Luciana Cezar de Cerqueira Leite
Journal:  Parasitol Res       Date:  2010-09-18       Impact factor: 2.289

4.  Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni.

Authors:  R Tarrab-Hazdai; D Schechtman; R Arnon
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  A novel 62-kilodalton egg antigen from Schistosoma mansoni induces a potent CD4(+) T helper cell response in the C57BL/6 mouse.

Authors:  H Asahi; H J Hernandez; M J Stadecker
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum.

Authors:  R Zhang; A Yoshida; T Kumagai; H Kawaguchi; H Maruyama; T Suzuki; M Itoh; M El-Malky; N Ohta
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats.

Authors:  Jorge Sepulveda; Jacqueline M Tremblay; Jon P DeGnore; Patrick J Skelly; Charles B Shoemaker
Journal:  Int J Parasitol       Date:  2010-06-30       Impact factor: 3.981

8.  A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization.

Authors:  R Arnon; R Tarrab-Hazdai; M Steward
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

9.  Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.

Authors:  Claudia Carvalho-Queiroz; Rosemary Cook; Ching C Wang; Rodrigo Correa-Oliveira; Nicola A Bailey; Nejat K Egilmez; Edith Mathiowitz; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Design and testing of PCR primers for the construction of scFv libraries representing the immunoglobulin repertoire of rats.

Authors:  Jorge Sepulveda; Charles B Shoemaker
Journal:  J Immunol Methods       Date:  2008-01-17       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.